A New Active Vitamin D, ED-71, Increases Bone Mass in Osteoporotic Patients under Vitamin D Supplementation: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial | Zendy

Toshio Matsumoto | Zendy; Takami Miki | Zendy; Hiroshi Hagino | Zendy; Toshitsugu Sugimoto | Zendy; Sumiaki Okamoto | Zendy; Takako Hirota | Zendy; Yusuke Tanigawara | Zendy; Yasufumi Hayashi | Zendy; Masao Fukunaga | Zendy; Masataka Shiraki | Zendy; Toshitaka Nakamura | Zendy

Open Access

A New Active Vitamin D, ED-71, Increases Bone Mass in Osteoporotic Patients under Vitamin D Supplementation: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Author(s) -

Toshio Matsumoto,

Takami Miki,

Hiroshi Hagino,

Toshitsugu Sugimoto,

Sumiaki Okamoto,

Takako Hirota,

Yusuke Tanigawara,

Yasufumi Hayashi,

Masao Fukunaga,

Masataka Shiraki,

Toshitaka Nakamura

Publication year - 2005

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2004-2552

Subject(s) - medicine , placebo , osteoporosis , vitamin d and neurology , bone mineral , bone remodeling , bone density , bone resorption , placebo controlled study , gastroenterology , endocrinology , randomized controlled trial , double blind , alternative medicine , pathology

ED-71 has been shown to increase lumbar bone mineral density (BMD) in osteoporotic subjects. However, vitamin D insufficiency might have influenced the effect of ED-71 on BMD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research